波音游戏-波音娱乐城赌球打不开

CityUHK’s IDM establishes partnership with Korea’s Samsung Advanced Institute for Health Sciences & Technology

 

M Yang
The MoU is signed by Professor Yang (left) and Professor Chang in Seoul, Korea.

The Institute of Digital Medicine (IDM) of City University of Hong Kong (CityUHK) and the Samsung Advanced Institute for Health Sciences & Technology (SAIHST) in Korea signed a Memorandum of Understanding (MoU) in Seoul on 18 March. It aims to establish collaboration on health-related research, particularly in cell and gene therapy, bioinformatics and biomedical engineering, as well as talent development and commercialising digital health solutions to benefit society.

The MoU was signed by Professor Michael Yang Mengsu, Senior Vice-President (Innovation and Enterprise) at CityUHK, and Professor Chang Yun Sil, Director of SAIHST.

SAIHST is a leading institute, jointly established by industry – Samsung Group, a hospital – Samsung Medical Center, and academia – Sungkyunkwan University (SKKU) – to advance research and nurture professional experts to lead the future of biomedical sciences. SAIHST is Korea’s first graduate school of interdisciplinary convergence medical science to conduct healthcare-focused research and education. The institute partnered with universities and research institutes in more than 10 countries, such as the United States, Canada, the United Kingdom, France, and partnership with domestic and global pharmaceutical companies, large corporations and biotech firms.

IDM was established in April 2024. In collaboration with renowned universities and medical schools around the world, as well as clinical and industry partners and health tech investors, IDM utilises CityUHK’s research strengths in engineering, data science and life science to develop innovative technologies to explore digital health solutions, for the long-term benefit of doctors and patients.

 “Global collaboration is crucial for the development of digital medicine,” said Professor Freddy Boey, President of CityUHK. “The partnership between IDM and SAIHST marks a significant milestone in advancing health technology innovation. With CityUHK’s dynamic innovation and entrepreneurial ecosystem, I am confident that our joint efforts will empower our future leaders on the global stage and create a positive impact on Hong Kong, Korea, and beyond.”

photo1
CityUHK's IDM and the SAIHST in Korea have established collaboration to advance health-related research, and promote talent development and commercialising digital health solutions, benefiting society in the long term.

IDM and SAIHST will establish talent-nurturing collaboration with an international perspective. SAIHST will support eligible top-tier researchers and scientists by facilitating their visits to Hong Kong, participating in programmes offered by the CityUHK Academy of Innovation, and providing internship opportunities for CityUHK students.

The two parties will strengthen their partnership in health-related innovations through CityUHK’s HK Tech 300 programme, jointly transforming innovative ideas into practical applications and promoting the development of deep-tech start-ups.

Following the signing ceremony, CityUHK's IDM delegation held discussions with professors from four SAIHST departments: Health Sciences and Technology, Digital Health, Medical Device Management and Research, and Clinical Research Design and Evaluation, and shared the development of CityUHK's IDM.

YOU MAY BE INTERESTED

Contact Information

Communications and Institutional Research Office

Back to top
大发888娱乐场客户端| 大发888送彩金| 百家乐最好投| 百家乐官网庄闲和各| 北京太阳城老年公寓| 澳门百家乐官网如何算| 金花百家乐的玩法技巧和规则 | 属猪与属狗 做生意| 开鲁县| 威尼斯人娱乐城老品牌值得您信赖lm0| 钻石娱乐城| 百樂坊百家乐的玩法技巧和规则| 博狗博彩网站,| 百家乐过两关| 百家乐官网推锅| 博彩排名| 威尼斯人娱乐备用622| 百家乐游戏算牌| 百家乐官网槛| 十六蒲娱乐城| 百家乐官网9人桌布| 德州扑克高牌| 百家乐奥| 百家乐路单之我见| 大发888安装需要多久| 尊龙百家乐娱乐平台| 免费百家乐官网预测工具| 百家乐官网庄闲的概率| 盛世国际开户| 安卓水果机游戏| 百家乐赢钱面面观| 百家乐游戏的玩法| 三亚百家乐官网的玩法技巧和规则| bet365体育在线注册| 百家乐筛子游戏| 百家乐官网薯片| 百家乐官网庄闲当哪个好| 乐业县| 伟博娱乐| 大发888线上娱乐百家乐| 威尼斯人娱乐城新闻|